Back to search

University of Ioannina

Ανάπτυξη καινοτόμων διαγνωστικών, θεραπευτικών και θεραπογνωστικών μορίων ανταποκρινόμενων στο μικροπεριβάλλον των καρκινικών κυττάρων με στόχο την εξατομικευμένη θεραπεία

Abstract

dc:description

Cancer is the second leading cause of death worldwide as it affects approximately 1/3 of the human population. Chemotherapy plays a vital role in the conventional treatment of various forms of cancer, however survival rates remain disappointing. The low efficacy rates are due to the fact that the already commercially available cytotoxic molecules have many gaps in their action. These are the low bioavailability of the drugs as well as their limited selectivity, which often leads to uncontrolled toxicity. In addition the development of new anticancer agents remains a highly expensive and inefficient process. Consequently, the scientific community has turned to alternative approaches. One such approach is the "recycling" of already existing drugs, which have not given satisfactory results and many of which have been withdrawn, with the aim of increasing their effectiveness through the use of suitable carriers that will be able to transport these drugs specifically to cancer cells cytotoxic molecules. It is important that these carriers have the ability to selectively release the cytotoxic molecule into the microenvironment of the cancer cells. Elevated levels of alkaline phosphatase (ALP) in the tumor microenvironment (TME) are a hallmark of cancer progression and thus inhibition of ALP could serve as an effective approach against cancer. Herein, we developed a novel prodrug approach to tackle cancer that bears self-inhibiting alkaline phosphatase-responsiveness properties that can enhance at the same time the solubility of the parent compound. To probe this novel concept, we selected apigenin as the cytotoxic agent since we first unveiled, that it directly interacts and inhibits ALP activity. Consequently, we rationally designed and synthesized, using a self-immolative linker, an ALP responsive apigenin-based phosphate prodrug, phospho-apigenin. Phospho-apigenin markedly increased the stability of the parent compound apigenin. Furthermore, the prodrug exhibited enhanced antiproliferative effect in malignant cells with elevated ALP levels, compared to apigenin. This recorded potency of the developed prodrug was further confirmed in vivo where phospho-apigenin significantly suppressed by 52.8% the growth of PC-3 xenograft tumors. Additional deficiencies are also encountered in the field of diagnosis, as there are no diagnostic molecules that allow early and non-invasive diagnosis. In order to achieve an early and valid diagnosis of cancer cells, we developed diagnostic compounds that emit in the region of the proximal hilum. These compounds respond to changes in the microenvironment of cancer cells, as they carry various molecular markers in their core, and target different cellular organelles, such as mitochondria and endoplasmic reticulum. Finally, innovative strategies were used and novel fluorescent compounds emitting in the Near Infrared were developed with the aim of inhibiting the AT2 receptor of the renin-angiotensin system (RAS). In particular, these compounds have the ability, after recognition-binding to the desired target, to change their fluorescence signal, through an aggregation induced emission (AIE) phenomenon. The compounds developed were evaluated for their cytotoxic activity in breast cancer cell lines expressing different levels of the AT2 receptor. In cell lines that express the AT2 receptor, we observe a significant reduction in cell growth. These results show that inhibition of the AT2 receptor is a promising strategy for the treatment of breast cancer.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsiailanis, Antonios
  • Τσιαϊλάνης, Αντώνιος

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55437

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsiailanis, Antonios; Τσιαϊλάνης, Αντώνιος. Ανάπτυξη καινοτόμων διαγνωστικών, θεραπευτικών και θεραπογνωστικών μορίων ανταποκρινόμενων στο μικροπεριβάλλον των καρκινικών κυττάρων με στόχο την εξατομικευμένη θεραπεία. University of Ioannina, 2023. http://hdl.handle.net/10442/hedi/55437